Best online clinics for Prozac

Finding quality mental health care has never been more important—or more confusing. The explosion of telehealth platforms over the past few years promised convenient access to treatment for conditions like anxiety, depression, ADHD, and insomnia. But recent industry shake-ups, regulatory crackdowns, and company closures have left many patients wondering: which telehealth providers can I actually trust?

If you’re considering online mental health treatment in 2026, understanding the current landscape is crucial. This comprehensive guide examines the major telehealth platforms still operating, what medications they will (and won’t) prescribe, and how to choose a provider that meets your needs safely and effectively.

The Telehealth Shakeout: What Happened to the Pioneers?

The telehealth mental health sector has undergone dramatic changes since its pandemic-era boom. While some providers have thrived, others have faced serious consequences for questionable practices.

Companies That Exited or Changed Course

Done Global, once a prominent ADHD telehealth provider, effectively ceased operations in 2024 after federal prosecutors indicted its top executives for allegedly running a scheme that inappropriately prescribed millions of Adderall pills. The Department of Justice characterized it as healthcare fraud that ‘exacerbated the nation’s opioid crisis’—a landmark case that sent shockwaves through the industry.

Ahead, another ADHD-focused startup, shut down in 2022 amid operational and financial challenges, leaving thousands of patients scrambling for alternative care.

Cerebral, perhaps the most well-known telehealth mental health startup, stopped prescribing all new stimulant ADHD medications in May 2022 under regulatory scrutiny. The company paid $3.6 million in settlements in 2024 related to past prescribing practices. While Cerebral still operates today, it has drastically scaled back its services and now takes what it calls a ‘conservative approach’ to medication management—avoiding all controlled substances including benzodiazepines and stimulants.

Why It Matters for Patients

These developments weren’t just business failures—they represented real harm to patients who suddenly lost access to their prescribers, faced pharmacy rejections, or received inadequate care. The aftermath created important lessons: convenience without clinical rigor is dangerous, and rock-bottom prices often signal corners being cut on quality.

For patients seeking care in 2026, the message is clear: choose providers with strong clinical governance, transparent policies, and a track record of regulatory compliance.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Who’s Still Standing? Major Telehealth Providers in 2025-2026

Despite the turbulence, several reputable telehealth platforms continue to serve patients across the United States. Here’s what you need to know about each:

Full-Service Psychiatric Telehealth

Talkiatry has emerged as a leader in insurance-based telepsychiatry. With licensed psychiatrists available in 43 states, Talkiatry can diagnose and treat the full spectrum of mental health conditions—including prescribing controlled substances like ADHD stimulants and benzodiazepines when medically appropriate.

Typical costs range from $25-$400 per visit depending on insurance coverage, with most patients paying standard psychiatric co-pays. The downside? Wait times can stretch 1-3 weeks for initial appointments due to high demand, and switching providers within insurance networks can be bureaucratic.

Specialty Mental Health Platforms

Brightside focuses exclusively on depression, anxiety, PTSD, OCD, and insomnia—but explicitly does not diagnose or treat ADHD. The platform takes pride in prescribing only ‘non-addictive’ medications, which means no controlled substances whatsoever: no stimulants, no benzodiazepines, no controlled sleep medications.

Brightside offers nationwide availability and accepts many insurance plans. Pricing runs $95/month for medication management alone, or $349/month for combined therapy and medication services. While the conservative medication approach appeals to some patients, it also limits treatment options for conditions that may benefit from controlled medications.

General Telehealth Giants

Teladoc, MDLive, and Amwell are the established players in broad-spectrum telehealth, covering everything from urgent care to dermatology to mental health. All three operate nationwide and work extensively with insurance plans.

However, these platforms have strict policies prohibiting controlled substance prescriptions via telehealth. You cannot get Adderall, Xanax, Ambien, or similar medications through these services—period. Their mental health offerings focus on mild-to-moderate depression and anxiety treated with non-controlled medications like SSRIs.

For patients seeking comprehensive psychiatric care including controlled medications, these general platforms simply won’t meet your needs. They’re best suited for straightforward concerns like starting an antidepressant or getting therapy referrals.

PlushCare straddles the line between general primary care and mental health. While it treats mild anxiety and depression, its controlled substance policy explicitly excludes ADHD stimulants, benzodiazepines, and sleep medications. Interestingly, PlushCare does prescribe GLP-1 medications for weight management and diabetes—a service the larger telehealth giants don’t offer. Pricing includes a $19.99/month membership plus $129 per visit.

Lifestyle-Focused Platforms

Hims & Hers has carved out a unique niche in wellness-focused telehealth, addressing anxiety, depression, hair loss, erectile dysfunction, skin care, and weight management. The platform does not prescribe any controlled substances, focusing instead on conditions treatable with non-controlled medications.

Hims & Hers launched GLP-1 weight loss services in 2023 and saw significant growth, though the FDA issued warnings in 2025 about marketing of compounded semaglutide products. Cash-pay pricing runs around $85/month for medication management, with therapy sessions available for $99 each. The platform does not accept insurance but is HSA-eligible.

The Controlled Substance Question: What Can You Actually Get Online?

Perhaps no issue is more important—or more confusing—than understanding which medications telehealth platforms will prescribe. Policies vary dramatically by provider and have tightened significantly since 2022.

ADHD Stimulants (Adderall, Ritalin, Vyvanse)

The telehealth landscape for ADHD stimulant prescriptions has fundamentally changed. After Done Global’s legal troubles and Cerebral’s policy reversal, very few direct-to-consumer platforms will prescribe Schedule II stimulants.

Who still prescribes ADHD stimulants?

• Talkiatry: Yes, through in-network psychiatrists when medically appropriate
• Klarity Health: Yes, with proper evaluation and ongoing monitoring

Who doesn’t?

• Cerebral (stopped in 2022)
• Brightside (policy exclusion)
• PlushCare, Teladoc, MDLive, Amwell (policy exclusions)
• Hims & Hers (no controlled substances)

For patients legitimately needing ADHD medication, this creates a real access challenge. The companies willing to prescribe stimulants responsibly now require more thorough evaluations, regular follow-ups, and documented treatment plans—which is appropriate clinical care, but does mean the ‘fill out a form, get Adderall tomorrow’ era is over.

Anti-Anxiety Medications (Xanax, Ativan, Klonopin)

Benzodiazepines have become even more restricted than stimulants in telehealth. Almost no direct-to-consumer platforms will prescribe them, citing addiction risks and regulatory concerns.

Talkiatry psychiatrists may prescribe benzodiazepines when appropriate, but even they use them cautiously and typically as short-term solutions. Most platforms instead offer SSRIs, SNRIs, or buspirone for anxiety—medications with better safety profiles but slower onset of action.

This policy shift reflects evolving medical consensus about benzodiazepine risks, but it does leave patients with severe anxiety disorders facing limited telehealth options. If you specifically need benzodiazepine management, an insurance-based psychiatric service or in-person care may be necessary.

Sleep Medications (Ambien, Lunesta)

The controlled ‘Z-drugs’ for insomnia face similar restrictions. Brightside, Teladoc, Amwell, and most other platforms explicitly exclude them from telehealth prescribing.

Instead, platforms typically offer:

• Non-controlled sleep aids like trazodone or doxepin
• Cognitive behavioral therapy for insomnia (CBT-I)
• Melatonin or other supplements
• Sleep hygiene counseling

For chronic insomnia sufferers who have found controlled sleep medications effective, this creates another access barrier in the telehealth space.

Weight Loss Medications: The GLP-1 Boom

While controlled substances have become harder to access via telehealth, one category has exploded: GLP-1 agonists for weight management (Wegovy, Ozempic, Mounjaro). These medications aren’t DEA-controlled, making them easier to prescribe online.

Hims & Hers led the charge, launching GLP-1 weight programs in 2023 and seeing stock surges of 5% when announcing expanded services. PlushCare also prescribes GLP-1s for qualified patients with obesity or metabolic conditions.

However, the FDA issued warnings in September 2025 about telehealth platforms selling compounded versions of these drugs, noting they aren’t FDA-approved substitutes for the brand-name medications. This regulatory action signals continued scrutiny of the telehealth weight-loss sector.

Traditional mental health platforms (Teladoc, Brightside, Talkiatry) generally don’t offer weight management services, seeing it outside their specialty scope.

State-by-State Availability: Can You Access These Services Where You Live?

Most major telehealth platforms now operate in all 50 states, but there are important nuances by state and provider.

California, Texas, Florida, New York, Pennsylvania, Illinois

These six high-population states are served by virtually all active platforms:

✅ Available in all six: Cerebral, Brightside, Talkiatry, PlushCare, MDLive, Teladoc, Amwell, Hims/Hers, Klarity Health

❌ Not available: Done (defunct), Ahead (closed)

Talkiatry’s State-by-State Limitations

While Talkiatry operates in 43 states (the most among psychiatric-specialty platforms), it’s not yet available everywhere. States without Talkiatry coverage as of late 2025 include Montana, Wyoming, South Dakota, North Dakota, Vermont, West Virginia, and Alaska. The company continues expanding but must obtain psychiatric licensing in each state.

Licensing and Regulations Matter

Even ‘nationwide’ platforms may have limitations. Providers must be licensed in your state of residence, and some state medical boards have specific telehealth restrictions. For instance:

• Some states require an initial in-person visit before controlled substance prescribing (though most waived this during COVID with extensions through late 2025)
• Certain states have stricter supervision requirements for nurse practitioners vs. physicians
• Insurance coverage varies significantly by state

Always verify a provider is licensed in your state before beginning treatment.

Pricing Transparency: What You’ll Actually Pay

Telehealth mental health costs vary dramatically depending on the business model, insurance coverage, and services needed.

Subscription Models

Cerebral: $99/month (medication management) to $365/month (therapy + medication)Brightside: $95/month (medication only) or $349/month (therapy + medication)Hims & Hers: $85/month for medication management

Subscription models offer predictability but can become expensive if you don’t need monthly visits. Many patients report frustration with being charged even during months they don’t use services, and cancellation can be difficult.

Insurance-Based Care

Talkiatry: $25-$400 per visit depending on insurance; typical co-pays are $30-$75Teladoc/MDLive/Amwell: Often $0-$50 with employer coverage or insurance

Insurance-based platforms offer the best value if you have good coverage, but may involve:

• Higher out-of-pocket costs if you haven’t met your deductible
• Limitations on provider choice
• Longer wait times for appointments
• Prior authorization requirements for medications

Pay-Per-Visit Models

PlushCare: $19.99/month membership + $129/visitKlarity Health: $149 initial evaluation, $59 follow-ups, $25 refill requests

Pay-per-visit pricing offers flexibility—you only pay when you need care. For patients with stable conditions requiring quarterly check-ins, this often costs less annually than monthly subscriptions.

Hidden Costs to Consider

Don’t forget to factor in:

• Medication costs: Not included in any platform’s pricing
• Therapy add-ons: Most medication-focused platforms charge separately for therapy
• Cancellation fees: Some platforms charge if you don’t provide adequate notice
• State-specific fees: A few platforms add state regulatory fees to visits

How Klarity Health Fits Into the 2026 Landscape

After reviewing the competitive landscape, where does Klarity Health fit in?

Klarity’s Differentiators

Comprehensive but Specialized: Unlike general platforms (Teladoc, Amwell) that won’t treat ADHD or prescribe controlled substances, Klarity focuses specifically on psychiatric conditions that often require comprehensive medication management—including ADHD, anxiety disorders, PTSD, insomnia, and mood disorders.

Responsible Controlled Substance Prescribing: While Cerebral and Brightside avoid controlled medications entirely, and Done’s reckless approach led to its downfall, Klarity takes a middle path: willing to prescribe stimulants, controlled sleep aids, and other scheduled medications when clinically appropriate, with proper evaluation and monitoring.

Transparent, Flexible Pricing: No monthly subscriptions. Klarity’s pay-per-visit model ($149 initial, $59 follow-ups) often costs less than Cerebral or Brightside subscriptions, especially for stable patients needing only occasional check-ins.

Provider Availability: While Talkiatry patients often wait weeks for appointments due to insurance network constraints, Klarity emphasizes faster access—often within days—and continuity of care with the same provider.

Insurance and Cash-Pay Options: Unlike cash-only platforms (Hims, Done, old-model Cerebral), Klarity accepts both insurance and self-pay, offering flexibility based on patient circumstances.

What Klarity Offers That Others Don’t

Many platforms have narrowed their scope after regulatory pressure. Klarity maintains treatment options for:

• Adult ADHD (including stimulant medications when appropriate)
• Insomnia (including controlled sleep medications when needed)
• PMDD/PMS (hormonal mood regulation)
• Binge eating disorder (an underserved condition)
• PTSD and complex trauma (requiring nuanced medication management)

This breadth matters. A patient with ADHD and comorbid anxiety can get comprehensive care through one provider, rather than using Talkiatry for ADHD stimulants, Brightside for anxiety SSRIs, and a separate platform for therapy.

The Trust Factor

In the post-Cerebral, post-Done landscape, patients are rightfully skeptical. They’ve seen headlines about prescription mills, heard stories of friends suddenly cut off from medications, and read about executive indictments.

Klarity can build trust by emphasizing:

• Clinical rigor: Thorough initial evaluations, not 10-minute rubber-stamp consultations
• Regulatory compliance: Adherence to DEA, FDA, and state medical board requirements
• Continuity: Ongoing relationships with the same provider, not rotating through whoever’s available
• Transparency: Clear policies about what can and cannot be prescribed, and why

The telehealth sector needs providers who can prescribe controlled substances responsibly—filling the gap between platforms that won’t prescribe them at all and those that allegedly prescribed them too freely.

Choosing the Right Telehealth Provider: Questions to Ask

Before committing to any telehealth mental health platform, ask yourself:

About Your Needs

1. What condition(s) am I seeking treatment for? If it’s straightforward depression or anxiety, many platforms will work. If it’s ADHD, insomnia, or complex psychiatric needs, your options narrow significantly.

2. Will I likely need controlled substances? If yes, rule out platforms with blanket policies against them (most general telehealth companies, Brightside, Hims/Hers).

3. Do I want therapy, medication management, or both? Some platforms specialize in one or the other. Combined services typically cost more.

4. How stable is my condition? If you’re in crisis or have very complex needs, insurance-based psychiatric care (Talkiatry) or in-person treatment may be more appropriate than any self-pay platform.

About the Provider

1. Who will I actually see? Psychiatrist (MD/DO), psychiatric nurse practitioner (PMHNP), primary care physician? Different credentials have different training levels and prescribing authorities.

2. Will I see the same provider consistently? Continuity of care improves outcomes, but some platforms rotate you through available providers.

3. How quickly can I get an initial appointment? Wait times range from same-day to several weeks.

4. What happens if I need urgent care or have a crisis? Most telehealth platforms aren’t equipped for psychiatric emergencies.

About Cost and Coverage

1. Does the platform accept my insurance? If yes, verify they’re in-network (not just ‘out-of-network with reimbursement’).

2. What’s my total monthly/annual cost? Add up subscription fees, visit costs, medication co-pays, and therapy if needed.

3. Can I pause or cancel easily? Read the fine print about cancellation policies and notice periods.

4. Are medications included or separate? All platforms charge separately for prescriptions, but some offer home delivery or pharmacy partnerships.

Red Flags to Watch For

• Promises of specific medications (especially controlled substances) before any evaluation
• Extremely low prices that seem too good to be true
• Lack of clear information about provider credentials
• Difficulty finding actual policy information on prescribing practices
• Aggressive marketing focused on getting specific drugs rather than comprehensive care
• Poor online reviews mentioning sudden service disruptions, cancelled refills, or billing issues

The Regulatory Environment: What’s Changing in 2026 and Beyond

The telehealth industry operates in a state of regulatory flux, with several important developments on the horizon.

The Ryan Haight Act Waiver

During COVID-19, the DEA waived requirements for an in-person medical evaluation before prescribing controlled substances via telehealth. This waiver has been repeatedly extended and currently runs through December 2025.

What happens in 2026? Congress and the DEA must decide whether to:

• Make the flexibility permanent
• Extend it again temporarily
• Let it expire, returning to the requirement for an in-person visit before controlled substance prescriptions

The industry is lobbying heavily for permanence, arguing it has enabled access for underserved populations. However, the Done Global indictment and concerns about prescription abuses give ammunition to those favoring stricter controls.

Impact on patients: If the waiver expires, you might need an initial in-person visit with a telehealth provider before they can prescribe ADHD stimulants, controlled sleep medications, or benzodiazepines. Ongoing refills could potentially continue via telehealth after that first visit.

FDA Scrutiny of Weight-Loss Telehealth

The FDA’s 2025 warning letters to platforms prescribing compounded GLP-1 medications signal heightened attention to the weight-loss telehealth sector. Expect potential regulatory changes around:

• Restrictions on compounded versions of brand-name GLP-1 drugs
• Requirements for more thorough screening before prescribing weight-loss medications
• Advertising restrictions on claims about weight-loss outcomes

State-Level Variations

Several states have introduced or are considering laws specifically governing telehealth mental health and controlled substance prescribing:

• California and New York have proposed requiring video (not just phone) visits for controlled substance prescriptions
• Texas continues to have some of the nation’s strictest telehealth regulations, including specific supervision requirements for nurse practitioners
• Florida has debated limiting controlled substance prescriptions to Florida-licensed providers only (not out-of-state telehealth)

These patchwork state regulations make nationwide telehealth complicated and may force some platforms to restrict services in certain states.

The Future of Mental Health Telehealth: Trends to Watch

Integration with In-Person Care

Expect more hybrid models combining telehealth with brick-and-mortar clinics. Some platforms are establishing partnerships with local practices to offer in-person evaluations when needed, maintaining telehealth for ongoing management.

This ‘tele-first, in-person when necessary’ approach may become the standard, especially if regulations tighten around purely virtual controlled substance prescribing.

Specialty Niches

Rather than trying to be all things to all people, successful platforms will likely specialize further:

• ADHD-specific services (with appropriate guardrails)
• Trauma and PTSD treatment including ketamine or psychedelic-assisted therapy
• Perinatal mental health and PMDD
• Sleep medicine telehealth
• Integrated mental and metabolic health (addressing both depression and weight management, for instance)

Klarity’s focus on specific underserved conditions (PMDD, binge eating disorder, complex insomnia) positions it well for this trend.

Measurement-Based Care

Leading platforms are increasingly incorporating standardized symptom tracking, validated screening tools, and outcome measurements. This ‘measurement-based care’ approach improves treatment effectiveness and also provides data to demonstrate value to insurers and regulators.

Patients should look for platforms that:

• Use validated screening tools (PHQ-9 for depression, GAD-7 for anxiety, etc.)
• Track symptoms over time
• Adjust treatment based on objective metrics, not just subjective reports
• Can demonstrate their patient outcomes

Consolidation Continues

The telehealth shakeout isn’t over. Expect more mergers, acquisitions, and closures as:

• Weaker companies run out of funding
• Insurance companies and health systems acquire specialized platforms
• Competition intensifies for the most profitable patient segments

For patients, this means choosing established, well-funded providers with clear pathways to long-term sustainability. A platform that might close in six months isn’t a good choice for managing chronic conditions.

Making Your Decision: A Framework for Choosing

Given all these factors, here’s a practical framework for selecting a telehealth mental health provider:

Step 1: Identify Your Needs

Primary condition(s): _Secondary concerns: _Medication status: New to treatment / Currently taking medications / Need refills onlyTherapy interest: Yes / No / Maybe

Step 2: Determine Your Medication Requirements

Based on your conditions, will you likely need:

• ☐ ADHD stimulants
• ☐ Anti-anxiety benzodiazepines
• ☐ Controlled sleep medications
• ☐ Antidepressants/anti-anxiety (non-controlled)
• ☐ Mood stabilizers
• ☐ Other: _

This determines which platforms are even options. If you need any controlled substances, eliminate Brightside, PlushCare, Teladoc, MDLive, Amwell, Hims/Hers, and current Cerebral.

Step 3: Consider Insurance vs. Self-Pay

Insurance considerations:

• Do you have good mental health coverage? → Consider Talkiatry or insurance-accepting platforms
• High deductible or poor coverage? → Self-pay platforms may cost less
• No insurance? → Focus on affordable self-pay options

Cost tolerance:

• Willing to pay $200-400/month? → Subscription platforms with therapy
• Prefer paying only when needed? → Pay-per-visit models
• Budget-constrained? → Insurance-based care or lower-cost platforms

Step 4: Evaluate Urgency and Availability

How soon do you need care?

• Urgent (within days): Klarity Health, some self-pay platforms
• Moderate (1-2 weeks): Most platforms
• Non-urgent (can wait 3-4 weeks): Talkiatry and insurance-based options

Step 5: Prioritize Your Values

What matters most to you?

• Maximum affordability: Insurance-based care (Talkiatry, employer-sponsored Teladoc)
• Convenience and speed: Self-pay platforms with quick access (Klarity, PlushCare)
• Comprehensive services: Platforms offering therapy + medication (Brightside, Cerebral, Klarity)
• Specialized expertise: Condition-specific platforms or full psychiatric care (Talkiatry, Klarity)
• Medication flexibility: Providers willing to prescribe controlled substances when appropriate (Talkiatry, Klarity)
• Conservative approach: Platforms avoiding controlled substances entirely (Brightside, Teladoc)

Step 6: Verify and Start

Before signing up:

1. ✓ Confirm the platform is licensed in your state
2. ✓ Read recent reviews (within the last 6 months)
3. ✓ Review their prescribing policy for your specific needs
4. ✓ Understand the total cost including visits, subscriptions, and estimated medication costs
5. ✓ Check their cancellation and refund policies
6. ✓ Verify they can prescribe through your preferred pharmacy

Getting Started with Klarity Health

If you’ve determined that Klarity Health aligns with your needs, here’s what to expect:

Initial Evaluation: A comprehensive 45-60 minute video visit with a licensed psychiatric provider. Unlike the rushed 15-minute consultations some platforms offer, Klarity prioritizes thorough assessment of your symptoms, history, and treatment goals.

Treatment Plan: Your provider will develop an individualized plan that may include medication, therapy referrals, lifestyle modifications, and follow-up scheduling. If medications are prescribed, you’ll receive clear information about what to expect, potential side effects, and monitoring requirements.

Ongoing Care: Follow-up visits (typically 15-30 minutes) allow your provider to assess treatment effectiveness, adjust medications if needed, and address any concerns. The pay-per-visit model means you schedule these as needed for your condition—some patients need monthly check-ins initially, while stable patients may stretch to quarterly visits.

Medication Management: Klarity’s willingness to prescribe controlled substances when clinically appropriate—with proper safeguards—fills a critical gap in the telehealth landscape. Whether you need ADHD stimulants, controlled sleep medications, or simply want access to a provider who can adjust treatment flexibly based on your response, Klarity offers comprehensive medication options.

Transparent Pricing: $149 for initial evaluation, $59 for follow-ups, and $25 for simple refill requests. No hidden fees, no mandatory monthly subscriptions, no surprise bills.

Conclusion: The Path Forward

The telehealth mental health landscape of 2026 is vastly different from the Wild West environment of 2020-2022. The platforms that survived the regulatory shakeout and competitive pressures are generally more responsible, clinically rigorous, and patient-focused than some of their defunct predecessors.

For patients, this evolution is ultimately positive. While the days of getting Adderall with a 10-minute online form are over (and good riddance), legitimate access to quality psychiatric care via telehealth is better than ever for those who choose wisely.

The key is matching your specific needs with a provider that can actually meet them:

• For comprehensive psychiatric care with insurance: Talkiatry
• For conservative medication management focused on non-controlled drugs: Brightside
• For urgent care and minor mental health concerns: Teladoc, MDLive, Amwell
• For primary care with limited mental health: PlushCare
• For lifestyle wellness and non-controlled conditions: Hims & Hers
• For specialized psychiatric treatment including responsible controlled substance management: Klarity Health

Don’t let the complexity overwhelm you. Start by honestly assessing your needs, ruling out platforms that can’t meet them, and then comparing the remaining options on cost, convenience, and quality factors that matter to you.

The future of mental health care is hybrid—combining the best of telehealth’s accessibility with the rigor and safety of traditional psychiatric practice. Choose providers that embody this balance, and you’re far more likely to receive care that genuinely improves your wellbeing.

Ready to get started with quality, accessible mental health care? Klarity Health’s licensed psychiatric providers are available across the United States to help you address ADHD, anxiety, depression, insomnia, PTSD, and other conditions with comprehensive, individualized treatment. Book your initial evaluation today and take the first step toward feeling better—with a provider you can trust.

Research Citations

1. Associated Press – ‘California Telehealth Executives Indicted in ADHD Drug Distribution Scheme’ (June 14, 2024)
https://apnews.com/article/498cb907623565ee680b33b1367efb84

2. TIME Magazine – ‘Why Online Therapy Startups Are Falling Short’ (November 1, 2022)
https://time.com/6225361/telehealth-startups-cerebral-done-ahead/

3. TechTarget Healthcare IT News – ‘Pushing ADHD Telehealth Prescriptions Costs Cerebral Millions’ (November 6, 2024)
https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions

4. Brightside Health – Official Medication Prescribing Policy and FAQ (Updated 2025)
https://www.brightside.com/faqs/what-medications-do-we-prescribe/

5. Associated Press – ‘FDA Warns Telehealth Companies Over Weight-Loss Drug Marketing’ (September 16, 2025)
https://apnews.com/article/9c08db3481dcfd67c433fad1ae07d941

Research Currency Statement: This article was verified as of January 4, 2026, using the most current available information from Department of Justice press releases, FDA announcements, official provider policy pages, and recent healthcare industry reporting.

Source:

• https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions#:~:text=Cerebral%20provides%20telehealth%20consultations%20for,from%20tiered%20monthly%20subscription%20plans
• https://finvsfin.com/hims-anxiety-reviews/#:~:text=Out%20of%20pocket%2C%20Hims%20will,99%20for%20each%20counseling%20session
• https://apnews.com/article/498cb907623565ee680b33b1367efb84#:~:text=Top%20executives%20of%20the%20California,executives%20of%20defrauding%20taxpayers%2C%20exacerbating
• https://time.com/6225361/telehealth-startups-cerebral-done-ahead/#:~:text=Halcyon%20Health%20and%20ADHD,Ahead%20shut%20down%20this%20year
• https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions#:~:text=Embattled%20telemental%20healthcare%20provider%20Cerebral,unauthorized%20distribution%20of%20controlled%20substances
• https://apnews.com/article/9c08db3481dcfd67c433fad1ae07d941#:~:text=The%20FDA%20has%20launched%20its,originals%2C%20which%20the%20FDA%20disputes
• https://www.teladochealth.com/info/prescription-policy#:~:text=pressure%20medication,well%20as%20Teladoc%20Health%20policy
• https://www.brightside.com/faqs/what-medications-do-we-prescribe/#:~:text=Note%3A%20Brightside%20does%20not%20prescribe,controlled%20substance%20in%20some%20states
• https://time.com/6225361/telehealth-startups-cerebral-done-ahead/#:~:text=substance%20prescriptions%20from%20Cerebral%20and,substance%20medications
• https://h-o-m-e.org/does-cerebral-prescribe-xanax/#:~:text=Cerebral%20takes%20a%20conservative%20approach,such%20as%20Xanax%20or%20Ativan